Impact of stress hyperglycemia on in-hospital stent thrombosis and prognosis in nondiabetic patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention

Coronary Artery Disease

Volumn 24, Issue 5, 2013, Pages 352-356

  Zhang, Jian Wei ^a   Zhou, Yu Jie ^a   Cao, Shu Jun ^b   Yang, Qing ^a   Yang, Shi Wei ^a   Nie, Bin ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

primary percutaneous coronary intervention; ST segment elevation myocardial infarction; stent thrombosis; stress hyperglycemia

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE MB; GLUCOSE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CORONARY RISK; CREATININE BLOOD LEVEL; DISEASE DURATION; DRUG ELUTING STENT; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART RATE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; IMPLANTED HEART PACEMAKER; INCIDENCE; INSULIN INFUSION; INTRAAORTIC BALLOON PUMP; ISCHEMIC PRECONDITIONING; LENGTH OF STAY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OBESITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; STRESS HYPERGLYCEMIA; SYSTOLIC BLOOD PRESSURE; THORAX PAIN;

AGED; BLOOD GLUCOSE; CHI-SQUARE DISTRIBUTION; CHINA; CORONARY THROMBOSIS; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; INCIDENCE; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; STRESS, PHYSIOLOGICAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 84880775454     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e328361a942     Document Type: Article

References (32)

1. Biteker M, Dayan A, Can MM, Ilhan E, Biteker FS, Tekkes in A, et al. Impaired fasting glucose is associated with increased perioperative cardiovascular event rates in patients undergoing major non-cardiothoracic surgery. Cardiovasc Diabetol 2011; 10:63.
2. Sanjuan R, Nunez J, Blasco ML, Minana G, Martinez-Maicas H, Carbonell N, et al. Prognostic implications of stress hyperglycemia in acute ST elevation myocardial infarction. Prospective observational study. Rev Esp Cardiol 2011; 3:201-207.
3. Timmer JR, Hoekstra M, Nijsten MW, van der Horst IC, Ottervanger JP, Slingerland RJ, et al. Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention. Circulation 2011; 124:704-711.
4. Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, et al. Universal definition of myocardial infarction. Circulation 2007; 116:2634-2653.
5. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008; 29:2909-2945.
6. Gwilt DJ, Petri M, Lamb P, Nattrass M, Pentecost BL. Effect of intravenous insulin infusion on mortality among diabetic patients after myocardial infarction. Br Heart J 1984; 51:626-630.
7. Lynch M, Gammage MD, Lamb P, Nattrass M, Pentecost BL. Acute myocardial infarction in diabetic patients in the thrombolytic era. Diabet Med 1994; 11:162-165.
8. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007; 115:2344-2351.
9. Bartnik M, Ryden L, Ferrari R, Malmberg K, Pyorala K, Simoons M, et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 2004; 25:1880-1890.
10. Norhammar A, Tenerz A, Nilsson G, Hansten A, Efendic S, Ryden L, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002; 359:2140-2144.
11. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Followup report on the diagnosis of diabetes mellitus. The expert committee of the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26:3160-3167.
12. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355:773-778.
13. Foo K, Cooper J, Deaner A, Knight C, Suliman A, Ranjadayalan K, et al. A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart 2003; 89:512-516.
14. Norhammar AM, Ryden L, Malmberg K. Admission plasma glucose. Independet risk factor for long-term prognosis after myocardial infarction even non-diabetic patients. Diabetes Care 1999; 22:1827-1831.
15. Stranders I, Diamant M, Van Gelder R, Spruijt H, JWR Twisk, Heine RJ, et al. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 2004; 164:982-988.
16. Timmer JR, Ottervanger JP, De Boer MJ, Dambrink J-HE, Hoorntje JCA, Gosselink ATM, et al. Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. J Am Coll Cardiol 2005; 45:999-1002.
17. Iwakura K, Ito H, Ikushima M, Kawano S, Okamura A, Asano K, et al. Association between hyperglycemia and the non-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 2003; 41:1-7.
18. Nakamura T, Ako J, Kadowaki T, Funayama H, Sugawara Y, Kubo N, Momomura S. Impact of acute hyperglycemia during primary stent implantation in patients with ST-elevation myocardial infarction. J Cardiol 2009; 53:272-277.
19. Timmer JR, Van Der Horst ICC, Ottervanger JP, Henriques JPS, Hoorntje JCA, De Boer MJ, et al. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am Heart J 2004; 148:399-404.
20. Chakrabarti AK, Singh P, Gopalakrishnan L, Kumar V, Elizabeth Doherty M, Abueg C, et al. Admission hyperglycemia and acute myocardial infarction: outcomes and potential therapies for diabetics and nondiabetics. Cardiol Res Pract 2012; 2012:704314.
21. Pinto DS, Kirtane AJ, Pride YB, Murphy SA, Sabatine MS, ChP Cannon, et al. Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITYTIMI-28 study). Am J Cardiol 2008; 101:303-307.
22. Kersten JR, Schmeling TJ, Orth KG, Pagel PS, Warttier DC. Acute hyperglycemia abolishes ischemic preconditioning in vivo. Am J Physiol 1998; 275:721-725.
23. Shechter M, Merz MB, Pau-Labrador MJ. Blood glucose and plateletdependent thrombosis in patients with coronary artery disease. J Am Coll Cardiol 2000; 35:300-307.
24. Oswald GA, Smith CC, Betteridge DJ, Yudkin JS. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. Br Med J (Clin Res Ed) 1986; 293: 917-922.
25. Lemkes BA, Hermanides J, DeVries JH, Holleman F, Meijers JCM, JBL Hoekstra. Hyperglycemia: a prothrombotic factor? J Thromb Haemost 2010; 8:1663-1669.
26. Vaidyula VR, Rao AK, Mozzoli M, Homko C, Cheung P, Boden G. Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand. Diabetes 2006; 55:202-208.
27. Vaidyula VR, Boden G, Rao AK. Platelet and monocyte activation by hyperglycemia and hyperinsulinemia in healthy individuals. Platelets 2006; 17:577-585.
28. Undas A, Wiek I, Stepien E, Zmudka K, Tracz W. Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome. Diabetes Care 2008; 31:1590-1595.
29. Mehta SR, Yusuf S, Diaz R, Zhub J, Pais P, Xavier D, et al. Effect of glucoseinsulin- potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 2005; 293:437-446.
30. Cheung NW, Wong VW, McLean M. The Hyperglycemia: Intensive Insulin Infusion In Infarction (HI-5) Study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 2006; 29:765-770.
31. Malmberg K, Norhammar A, Wedel H, Ryde'n L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999; 99:2626-2632.
32. Malmberg K, Ryde'n L,Wedel H, Birkeland K, Bootsma A, Dickstein K, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005; 26:650-661.